BlackRock’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10M | Buy |
1,895,655
+46,408
| +3% | +$245K | ﹤0.01% | 3366 |
|
2025
Q1 | $15.1M | Sell |
1,849,247
-19,356
| -1% | -$158K | ﹤0.01% | 3060 |
|
2024
Q4 | $23.9M | Buy |
1,868,603
+8,084
| +0.4% | +$103K | ﹤0.01% | 2886 |
|
2024
Q3 | $19.9M | Buy |
1,860,519
+76,756
| +4% | +$823K | ﹤0.01% | 3005 |
|
2024
Q2 | $14.1M | Buy |
1,783,763
+34,183
| +2% | +$271K | ﹤0.01% | 3133 |
|
2024
Q1 | $28M | Sell |
1,749,580
-56,569
| -3% | -$907K | ﹤0.01% | 2743 |
|
2023
Q4 | $24.8M | Buy |
1,806,149
+88,867
| +5% | +$1.22M | ﹤0.01% | 2835 |
|
2023
Q3 | $25.1M | Buy |
1,717,282
+46,718
| +3% | +$683K | ﹤0.01% | 2765 |
|
2023
Q2 | $28.4M | Buy |
1,670,564
+1,187,767
| +246% | +$20.2M | ﹤0.01% | 2755 |
|
2023
Q1 | $6.74M | Buy |
482,797
+6,995
| +1% | +$97.7K | ﹤0.01% | 3429 |
|
2022
Q4 | $3.14M | Buy |
475,802
+1,419
| +0.3% | +$9.37K | ﹤0.01% | 3862 |
|
2022
Q3 | $2.5M | Sell |
474,383
-2,507
| -0.5% | -$13.2K | ﹤0.01% | 3992 |
|
2022
Q2 | $2.27M | Sell |
476,890
-1,090,740
| -70% | -$5.18M | ﹤0.01% | 4125 |
|
2022
Q1 | $13.3M | Sell |
1,567,630
-20,962
| -1% | -$178K | ﹤0.01% | 3350 |
|
2021
Q4 | $19M | Buy |
1,588,592
+17,239
| +1% | +$207K | ﹤0.01% | 3244 |
|
2021
Q3 | $27.8M | Buy |
1,571,353
+3,270
| +0.2% | +$57.9K | ﹤0.01% | 3019 |
|
2021
Q2 | $32.2M | Buy |
1,568,083
+1,290,956
| +466% | +$26.5M | ﹤0.01% | 2957 |
|
2021
Q1 | $5.49M | Buy |
277,127
+126,829
| +84% | +$2.51M | ﹤0.01% | 3842 |
|
2020
Q4 | $2.79M | Buy |
150,298
+18,632
| +14% | +$346K | ﹤0.01% | 3853 |
|
2020
Q3 | $3.31M | Buy |
+131,666
| New | +$3.31M | ﹤0.01% | 3651 |
|
2020
Q1 | – | Sell |
-1
| Closed | – | – | 4963 |
|
2019
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4980 |
|